Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD

BMJ Open Respiratory Research

Volumn 3, Issue 1, 2016, Pages

  Kreindler, James L ^a   Watkins, Michael L ^a   Lettis, Sally ^b   Tal Singer, Ruth ^a   Locantore, Nicholas ^a  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85052233987     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2016-000151     Document Type: Article

References (12)

1. Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005; 60: 193-8.
2. Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in subjects with severe eosinophilic asthma. N Engl J Med 2014; 371: 1198-207.
3. Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: A randomized placebo-controlled trial. Am J Respir Crit Care Med 2012; 186: 48-55.
4. Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: A secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 2015; 3: 435-42.
5. Siddiqui SH, Guasconi A, Vestbo J, et al. Blood eosinophils: A biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192: 523-5.
6. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008; 31: 869-73.
7. Hodges JR, Lehmann EL. Estimates of location based on rank tests. Ann Math Stat 1963; 34: 598-611.
8. Summary: CTR Summary for MDC-GSK Clinical Study Register. http://www. gsk-clinicalstudyregister. com/files2/21078. pdf (accessed 1 Aug 2016).
9. Pizzichini E, Pizzichini MM, Gibson P, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998; 158 (Pt 1): 1511-17.
10. Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: A randomised controlled trial. Eur Respir J 2007; 29: 906-13.
11. Liesker JJ, Bathoorn E, Postma DS, et al. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. Respir Med 2011; 105: 1853-60.
12. Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-8.